- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Undervalued Small Caps
U.S. Pharmaceuticals & Biotech Undervalued Small Caps
Results
6
Undervalued Small Caps
6 companies
Zevra Therapeutics
Market Cap: US$474.6m
A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.
ZVRA
US$8.43
7D
-2.0%
1Y
-9.6%
Abeona Therapeutics
Market Cap: US$274.8m
A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.
ABEO
US$5.07
7D
13.2%
1Y
-20.7%
SIGA Technologies
Market Cap: US$434.0m
A commercial-stage pharmaceutical company, focuses on the health security market in the United States.
SIGA
US$6.06
7D
3.8%
1Y
-16.8%
CureVac
Market Cap: US$1.2b
A biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA).
CVAC
US$5.49
7D
9.1%
1Y
91.3%
Niagen Bioscience
Market Cap: US$542.2m
Operates as a bioscience company engages in developing healthy aging products.
NAGE
US$6.77
7D
-1.6%
1Y
-12.3%
MiMedx Group
Market Cap: US$1.0b
Develops and distributes placental tissue allografts for various sectors of healthcare.
MDXG
US$6.88
7D
1.8%
1Y
-25.6%